The People Behind Mach7

Teri Thomas is the CEO and Managing Director of Mach7 Technologies, bringing global experience in healthcare technology, operational leadership, and strategic growth. Before joining Mach7, Teri was CEO of Volpara Health Technologies (ASX:VHT), where she led a successful turnaround and positioned the company for its acquisition by Lunit, where she also served as Chief Business Officer. She previously spent 20 years in a variety of roles at Epic, the leading US electronic medical record company, and held executive roles at Orion Health, overseeing global sales and corporate development.

A registered nurse with a Master of Science degree, Teri pairs clinical insight with a proven track record in scaling businesses, delivering operational efficiencies, and fostering strong, mission-driven cultures. She is committed to leading Mach7 through its next phase of growth and innovation in medical imaging and data management.

Shawni Hadfield serves as Interim Chief Financial Officer at Mach7 Technologies, where she leads the company’s financial strategy, planning, and performance. In this role, she partners closely with the executive team to align financial discipline, capital allocation, and operational execution with Mach7’s growth objectives and commitment to innovation in enterprise imaging.

Previously, Shawni served as Vice President of Commercial Excellence, where she was responsible for optimizing the company’s commercial strategy and revenue operations. During her tenure, she helped build a more scalable commercial foundation by aligning strategy, operations, and analytics across revenue-generating functions to support sustainable growth.

Shawni brings more than 15 years of international experience across finance, strategy, and operations. She previously served as Chief Financial Officer of a high-growth global SaaS business, where she drove strong revenue growth, improved profitability, and supported international expansion. Earlier in her career, she advised organizations across five countries on corporate finance, M&A, restructuring, and operational transformation, working with both growth-stage companies and large enterprises.

A Chartered Accountant and CFA Charterholder, Shawni combines financial rigor with a strong strategic and operational mindset. She is known for translating strategy into execution, building scalable systems, and helping organizations operate with clarity and confidence.

Shawni is passionate about helping healthcare organizations overcome the limitations of siloed technologies and legacy systems, enabling them to unlock the full potential of enterprise imaging for clinicians, patients, and operational leaders alike.

Brian Wehrle is Chief Technology Officer at Mach7 Technologies, where he leads the company’s global engineering and support organizations, as well as its overall technology strategy. In this role, Brian is responsible for advancing Mach7’s enterprise imaging platform, driving innovation across cloud, AI, and workflow orchestration, and ensuring the company delivers scalable, high-performance solutions with a strong, customer-first focus.

Brian brings more than 25 years of experience in healthcare technology, software engineering, and product development. Prior to joining Mach7, he served as Vice President of Software Engineering – Medical Imaging at Clario, where he led a global team of approximately 150 professionals across engineering and related functions and drove the expansion of AI and machine learning capabilities across the organization.

Earlier in his career, Brian held senior leadership roles at Asure Software and GE Healthcare, where he led large-scale engineering teams, modernized development practices, and delivered measurable improvements in product quality, operational efficiency, and customer satisfaction. His experience spans SaaS platforms, enterprise healthcare systems, and the application of emerging technologies to solve complex clinical and operational challenges.

Brian is passionate about building high-performing teams and fostering a culture of continuous improvement, collaboration, and accountability. He is known for combining technical depth with a pragmatic, customer-focused approach, ensuring that innovation is closely aligned with real-world customer needs and outcomes.

Todd Stallard is Executive Vice President of Commercial at Mach7 Technologies, where he leads the company’s global revenue engine across enterprise sales, channel partnerships, and marketing. In this role, he is responsible for driving growth, strengthening strategic alliances, and advancing Mach7’s position as a leader in enterprise imaging.

Todd brings more than two decades of experience in product marketing, go-to-market strategy, and commercial leadership across SaaS, enterprise software, and emerging technologies. He has a proven track record of building and scaling high-performing teams, aligning sales and marketing organizations, and delivering measurable results in competitive, fast-evolving markets.

Prior to joining Mach7, Todd held leadership roles at companies including Microsoft, Sigma Connectivity, and ApoQlar, where he led global partnerships, developed go-to-market strategies, and expanded market presence across healthcare, IoT, and advanced visualization technologies. At Microsoft, he spent 17 years in senior sales and channel leadership roles, driving large-scale partner ecosystems and revenue growth initiatives.

Known for his customer-first mindset, Todd excels at translating complex technology into clear business value. He is passionate about helping healthcare organizations adopt innovative solutions that improve access to imaging, enhance clinical workflows, and ultimately support better patient outcomes.

Ross Carbone is General Counsel at Mach7 Technologies (ASX: M7T), leading the legal function across commercial contracts, M&A, corporate governance, securities, and compliance.

Ross joins Mach7 with more than a decade of in-house and law-firm experience in corporate transactions. Most recently, as Associate General Counsel & Assistant Corporate Secretary at AnewHealth (NASDAQ: TRHC), he served as a generalist attorney across commercial transactions, M&A, corporate governance, securities, litigation, intellectual property, and employment law. He previously led M&A and strategic transactions as in-house counsel at BD (NYSE: BDX), and practiced corporate law at DLA Piper and McCarter & English.

Ross holds a J.D. from Rutgers Law School and a B.A. in International Politics & Economics from Middlebury College, and is pursuing an MBA at the University of Michigan's Ross School of Business. He is fluent in Italian.

Kelly Kimball is VP, People & Culture at Mach7 Technologies, partnering with executive leadership and the board to build the leadership capability, culture, and talent strategy behind Mach7's growth.

Kelly brings 17 years of HR and people leadership experience across renewable energy, healthcare, and automotive industries. Before Mach7, she held senior HR business partner roles at EBlock, VEIC, and Aspenti Health, and spent nearly a decade building HR operations from the ground up at Renewable NRG Systems. Across every role, her focus has been the same: treating People as a business function measured on outcomes, not just a support function — building high-performing teams, modernizing People operations, and aligning talent strategy directly to business goals.

Kelly holds an Associate's degree in Business/Commerce from Champlain College.

Carrie Nadolski is VP, Client Success & Service Excellence at Mach7 Technologies, where she leads the team responsible for making sure customers get sustained value from their enterprise imaging investment long after go-live.

Carrie has spent her entire career in healthcare IT, with more than eight years at Mach7 spanning Professional Services Engineer, Professional Services Manager, and now VP roles, preceded by nearly a decade as a Technical Support Engineer at GE Healthcare — including its acquisition of IDX Systems Corporation, where she began her career, and deep hands-on work with HL7 and healthcare systems integration. That continuity gives her a ground-level view of how imaging systems are deployed, supported, and adopted in hospital IT environments, which she applies to building service and client-success programs that catch issues before they become escalations.

Carrie holds a B.S. in Computer Science and Information Systems from the University of Vermont.

Mike Moore leads Growth, Market Development & Customer Success at Mach7 Technologies, where he's building the go-to-market engine that connects direct sales, strategic partnerships, and the Account & Customer Experience (ACE) team around one goal: turning enterprise imaging modernization into measurable pipeline, retention, and expansion.

Mike brings more than 20 years of partner-led growth leadership in healthcare IT and enterprise technology, including senior alliance and channel roles at Microsoft, GE Healthcare, Datto, and Productive Edge, where he built hyperscaler and data ecosystems spanning Microsoft, AWS, Google Cloud, Snowflake, and Databricks. He is the co-author of Marketing Multiplied, a practical guide to channel marketing, and holds a B.S. in Management from Lesley University.

Outside Mach7, Mike is a certified drone pilot and flight instructor, teaching aerial photography and videography courses across New England.

Andrew Volkening is Vice President of Product at Mach7 Technologies, leading product strategy for Mach7's enterprise imaging and diagnostic viewing platforms.

Andrew brings more than 15 years of hands-on healthcare imaging experience, starting as a field service engineer before spending nearly 14 years as PACS Administrator at Sunnybrook Health Sciences Centre, one of Canada's largest teaching hospitals and trauma centers. That direct, in-the-trenches PACS experience shapes how he approaches product decisions today — starting from what actually happens on a hospital floor, not just what a spec sheet says. He later led clinical solutions at Client Outlook, maker of the eUnity viewer, before Mach7 acquired the company in 2020 and he stepped into product leadership. Andrew is also an award-winning imaging researcher, recognized for his work developing Canadian guidelines for lossy compression in medical imaging.

Andrew is based in Toronto, Ontario.

Trinity Urban is a Technology Strategist, Enterprise Imaging at Mach7 Technologies, bringing more than two decades of experience building regulated, large-scale imaging platforms for oncology and clinical research.

Most recently Director of Product Management at Clario, Trinity led AI-driven product strategy for a cloud-based imaging platform used to accelerate clinical trials, aligning a 50-person global team across product, engineering, and quality within FDA, HIPAA, and GCP requirements. She spent 17 years at Massachusetts General Hospital, where she built and scaled SaaS-based imaging platforms for oncology clinical trials — one scaling to more than $8M in annual revenue across 10 NCI-designated cancer centers — and co-founded Crowds Cure Cancer, a crowdsourced tumor-measurement platform that helped accelerate AI model development in oncology. She is also a founding member of the Open Health Imaging Foundation, shaping the open-source standards behind OHIF and Cornerstone3D.

Trinity holds a Master of Liberal Arts in Biotechnology from Harvard University and a B.A. in English Literature and Technical Writing from Pennsylvania State University.

David Russo is Senior Director, Regulatory Affairs & Quality at Mach7 Technologies, where he oversees global regulatory strategy and quality systems for Mach7's enterprise imaging platforms and diagnostic viewers.

David brings more than 15 years of regulatory and quality leadership in medical imaging software and healthcare IT, with deep expertise in ISO 13485 quality management systems, risk management (ISO 14971), software validation, and FDA submissions. He is an ASQ Certified Manager of Quality/Organizational Excellence and an ISO 13485 Lead Auditor. Before Mach7, David built and scaled quality systems as Vice President of Operations and Director of Quality Assurance at Data Innovations, and spent a decade at GE Healthcare — including its acquisition of IDX Systems Corporation — leading quality management and FDA regulatory validation for healthcare IT projects.

David holds a B.S. in Applied Economics and Business Management from Cornell University's Dyson School.

Zaleera Tharel Vasu is VP, Operations APAC at Mach7 Technologies, leading end-to-end operational strategy across finance, HR, sales operations, and regulatory compliance for the Asia-Pacific region out of Singapore.

Zaleera has spent more than 12 years with Mach7's Singapore operation, rising from Senior Accountant to APAC Operations Manager to her current VP role. She brings 24 years in finance, including statutory audits, tax, and GST compliance across multiple APAC markets, plus a decade of HR leadership spanning payroll, recruitment, performance management, and training. She rounds out that base with regulatory expertise in HSA and GDPMDS audits and hands-on support for sales operations — pricing, contract administration, and CRM. That combination gives her a rare, ground-up view of how a regional healthcare IT operation actually runs day to day.

Zaleera holds a Bachelor's degree in Accounting and Finance from Hislop College and an Advanced Diploma in Information Technology.

Veera Palaniappan joins Mach7 Technologies as Regional Healthcare Sales & Country Leader, based in Kuala Lumpur, bringing more than 23 years of regional healthcare and life sciences leadership across Southeast Asia.

Most recently Regional Healthcare Sales & Country Director for Malaysia and Brunei at Dedalus APAC, Veera has built and run P&L-owning regional businesses across ASEAN, AMEA, and APAC for organizations including DXC Technology, RamSoft, iSOFT/CSC, and Agfa HealthCare, spanning enterprise imaging (PACS, RIS, CR, Cardio PACS), diagnostics, and healthcare informatics. His background combines direct sales leadership with product management and channel strategy, giving him a full-funnel view of how healthcare IT solutions get positioned, sold, and delivered across diverse Southeast Asian markets.

Veera holds a Bachelor's degree in Biomedical Engineering from the University of Alabama at Birmingham and an Associate's degree in Healthcare Leadership from the NUS Yong Loo Lin School of Medicine.

Ravi is a founding partner of Mach7 Technologies and is an accomplished image management professional with two decades of experience with the technology intricacies that drive medical imaging.

Ravi is a DICOM and image workflow expert. He has been instrumental in the growth of industry-leading healthcare teams, including GE Healthcare and Agfa Healthcare

As one of the two co-founders of Mach7, Ravi has shaped its design philosophy and technical strategy. In his capacity as Strategic Advisor to the CEO, he works closely with the Chief Executive Officer, leveraging his wealth of experience, relationships, and expertise to help drive the future of Mach7.

BSc, LLB, MBA
 
Rob is an experienced Chair, non-executive director, and business leader, with over 30 years’ experience in law, corporate finance and corporate advisory.

Rob has a demonstrated track record of leading and growing large scale and complex businesses.  He has played a significant role in advising corporations (public, private, and global subsidiaries) on commercial matters, public transitions, corporate governance, and Mergers and Acquisitions.

His prior professional experience includes commercial law, investment banking, and in professional services with global consulting firm KPMG in multiple senior roles. 
 
Current directorships:          
Non-Executive Director: OFX Group Limited (ASX:  OFX).
Chair:  Natrio Asia Pacific Pty Limited
Chair: ORDE Financial Holdings Pty Limited.
Chair of NALSPA Limited.  (National Automotive Leasing & Salary Packaging Ltd).
 
Previous directorships (last 3 years):
Director: Keypath Education International Inc.

Teri Thomas is the CEO and Managing Director of Mach7 Technologies, bringing global experience in healthcare technology, operational leadership, and strategic growth. Before joining Mach7, Teri was CEO of Volpara Health Technologies (ASX:VHT), where she led a successful turnaround and positioned the company for its acquisition by Lunit, where she also served as Chief Business Officer. She previously spent 20 years in a variety of roles at Epic, the leading US electronic medical record company, and held executive roles at Orion Health, overseeing global sales and corporate development.

A registered nurse with a Master of Science degree, Teri pairs clinical insight with a proven track record in scaling businesses, delivering operational efficiencies, and fostering strong, mission-driven cultures. She is committed to leading Mach7 through its next phase of growth and innovation in medical imaging and data management.

Dr. Eliot L. Siegel is a recognised thought leader in radiology, imaging informatics, and the application of artificial intelligence in medicine. He currently serves as a Professor in the Department of Diagnostic Radiology at the University of Maryland School of Medicine and holds a dual appointment with the Bioengineering Department at the University of Maryland, College Park.

A pioneer in clinical innovation, Dr. Siegel is a co-founder of United Theranostics, a company focused on expanding patient access to state-of-the-art radiopharmaceutical cancer therapies. He previously served as the Chief of Imaging Services for the Veterans Affairs Maryland Healthcare System from 1987 to 2022. Under his visionary leadership, the VA Maryland Healthcare System made history as the world's first filmless healthcare enterprise.

A prolific contributor to academic literature, Dr. Siegel has authored hundreds of articles and book chapters on Picture Archiving and Communication Systems (PACS), digital imaging, and medical imaging informatics. He has edited numerous foundational texts, including Filmless Radiology and Security Issues in the Digital Medical Enterprise, and most recently served as the editor of the PET/CT edition of the academic journal Radiological Clinics of North America. His extensive publication history heavily explores the clinical translation of artificial intelligence in radiology, cloud technologies for medical imaging, and advancements in positron emission tomography (PET) protocols.

An internationally sought-after speaker, Dr. Siegel has delivered more than 1,000 presentations worldwide on the intersection of computers, artificial intelligence, and clinical medicine. He has directed programs for the SPIE Medical Imaging Conference and is a distinguished Fellow of the American College of Radiology (ACR). In recognition of his exceptional contributions to the field, he was awarded the Gold Medal from the Society for Imaging Informatics in Medicine (SIIM).

As a member of the Mach7 Board of Directors, Dr. Siegel leverages his decades of clinical, academic, and practical expertise in enterprise imaging, AI integration, and workflow optimization to help guide the company's strategic vision.

Audit and Risk Committee Chair

BEc, Grad Dip Applied Finance & Investment, GAICD

Rebecca is an experienced non-executive director, Audit and Risk Committee Chair, and capital markets professional with more than 25 years' experience across global investment banking, ASX-listed companies, SaaS and technology businesses, real assets, and the not-for-profit sector. She has a demonstrated track record in financial oversight, enterprise risk management, capital allocation, ESG governance, strategic communications, and stakeholder engagement. Rebecca has advised boards and executive teams through capital raisings, mergers and acquisitions, sustainability initiatives, governance challenges, and strategic transformation.

Her prior professional experience includes senior leadership roles with J.P. Morgan, KPMG Advisory, CSR Limited, and Valad Property Group, as well as equity research and financial journalism. She is also co-founder of MarketMeter, an investor sentiment and data analytics platform serving ASX-listed companies and institutional investors.

Current directorships:

Non-Executive Director and Audit & Risk Committee Chair: Mach7 Technologies Ltd. (ASX: M7T).

Non-Executive Director and Chair, Finance, Risk & Audit Committee: Independent Community Living Australia (ICLA).

Co-Founder and Non-Executive Director: MarketMeter.